Clifford Chance advises on Beauty Farm’s Hong Kong IPO and Listing
16 January 2023
Clifford Chance advises on Beauty Farm’s Hong Kong IPO and Listing
Leading international law firm Clifford Chance has advised the joint sponsors Morgan Stanley, Haitong International, and Huatai Financial Holdings on Beauty Farm Medical and Health Industry Inc.’s HK$783 million (US$100 million) initial public offering and listing on the mainboard of the Hong Kong Stock Exchange.
Partners Fang Liu and Virginia Lee led the Clifford Chance team advising on the deal, which also includes counsel Lorna Lyu and Claire Cao, senior associates Qingyu Wu and Joy Chen, associates Belinda Cai, Yaping Li and Yuer Shao, and legal analysts Serena Shen and Hao Lin.
Beauty Farm is the largest provider of traditional beauty services and the fourth largest non-surgical aesthetic medical service provider in China, as measured by revenue in 2021. It operates a growing nationwide store network consisting of its flagship BeautyFarm brand, as well as emerging brands such as Palaispa, CellCare, and Neology.
The firm's market-leading Greater China IPO practice have advised on the listings of China’s most significant retail and consumer companies, including Giant Biogene (collagen-based professional skincare products), Shanghai Chicmax Cosmetic (skincare, maternity and childcare products) and Weilong Delicious (leading spicy snack food company in China).
高伟绅助力美丽田园香港IPO和上市
国际领先律师事务所高伟绅就美丽田园医疗健康产业有限公司首次公开募股募集7.83亿港元(约1亿美元)和香港联交所主板上市,为联席保荐人摩根士丹利、海通国际和华泰金融控股提供法律服务。
本次交易由合伙人方刘和李婉雯共同领导,团队成员包括吕娜、曹阳、吴擎宇、陈嘉烨、蔡彬霖、李亚平、邵钰儿、沈拓和林好。
按2021年营业额计算,美丽田园是中国最大的传统美容服务提供商和第四大的非外科手术类医疗美容服务提供商。美丽田园的全国连锁店的规模不断扩大, 品牌包括旗舰品牌以及新兴品牌贝黎诗、秀可儿和启研。
市场领先的高伟绅大中华区IPO团队曾为中国多个大型零售和消费品公司的上市提供法律服务,其中包括巨子生物(胶原蛋白专业护肤品)、上海上美化妆品股份有限公司(护肤品及母婴护理产品)和卫龙美味(中国大型辣味食品公司)。